Early development of the Toll-like receptor 9 agonist, PF-3512676, for the treatment of patients with advanced cancers.
Tarhini AA, Kirkwood JM, Krieg AM. Early development of the Toll-like receptor 9 agonist, PF-3512676, for the treatment of patients with advanced cancers. Expert Opin Drug Discov. 2009 May; 4(5):587-603.